A practical comparison of Rejuran, Juvelook, and exosome skin treatments at Orta Clinic in Gangnam, Seoul — how each works, published prices in KRW, downtime, aftercare for international visitors, and what the clinical research says.
If you're searching for "glass skin" treatments in Seoul, you'll quickly run into three names: Rejuran, Juvelook, and exosome therapy. They are often mentioned together, but they work in different ways, cost different amounts, and suit different skin concerns. Juvelook itself comes in two forms — Juvelook (skin booster) for skin quality and Juvelook Volume for restoring volume — and they are not interchangeable. This guide compares all of them as offered at Orta Clinic, a dermatology clinic on Gangnam-daero in Seocho-gu, Seoul — a short walk from both Gangnam Station and Sinnonhyeon Station — including published prices in KRW, expected downtime, and what the clinical research actually supports.
Information current as of September 2026. Prices change monthly with promotions, and treatment plans and final quotes are confirmed at an in-person consultation.
Rejuran | Juvelook (Skin Booster) | Juvelook Volume | Exosome (ASCE) | |
|---|---|---|---|---|
Main ingredient | Polynucleotides (PN), derived from salmon DNA | Poly-D,L-lactic acid (PDLLA) with hyaluronic acid | Poly-D,L-lactic acid (PDLLA) with hyaluronic acid, in a volumizing formulation | Exosome-containing solution, typically applied with microneedling |
Primary goal | Skin quality: texture, hydration, fine lines, barrier repair | Collagen stimulation for loss of elasticity, fine wrinkles, and skin that has become thin and fragile | Collagen stimulation to restore volume in a specific area | Calming and regeneration support for sensitive skin, rosacea, or skin that has become reactive after a procedure |
How it is performed | Injected into the dermis with a needle. Because it is placed in a shallow layer, injection bumps appear and the procedure feels more uncomfortable | Injected with a needle into the subcutaneous fat layer beneath the dermis. Because it is placed deeper, injection bumps are uncommon and discomfort is milder | Placed with a cannula into the area where volume is wanted. A nerve block is given beforehand, so the procedure itself is essentially pain-free | Absorbed through microneedling with a dermapen, so there are almost no visible marks and very little discomfort |
Typical course | 2–4 sessions, 2–3 weeks apart | 1–3 sessions, about a month apart | 1–3 sessions, about a month apart | No fixed interval — usually done whenever redness or breakouts flare up |
Downtime | Red needle marks and small injection bumps, usually 1–3 days, occasionally up to 7 | Red needle marks, usually 1–3 days, occasionally up to 7. Injection bumps are uncommon | Mild swelling or tenderness in the treated area for 2–3 days | Slight redness from the microneedling, about 1 day and at most 3 |
As a rough guide: if your main concern is dull, dehydrated skin or texture (a common concern in your late 20s to 30s), Rejuran is usually the first option discussed. If the concern is loss of elasticity, fine wrinkles, or skin that has become thin and fragile, Juvelook — a collagen stimulator — is more relevant. If the concern is lost volume in a specific area, that is what Juvelook Volume is for. Exosome therapy is generally an add-on for calming sensitive or reactive skin rather than a standalone fix. The right choice depends on your skin, which is why a consultation comes first.
Rejuran (polynucleotides). A 2025 systematic review of randomized clinical trials found that polynucleotide and polydeoxyribonucleotide injections improved wrinkle-related outcomes, scar quality, and patient-reported satisfaction across the included studies (Cureus, 2025). Evidence is encouraging but still based on relatively small trials, so results vary between individuals.
Juvelook (PDLLA). PDLLA works as a biodegradable collagen stimulator: the particles gradually dissolve while stimulating fibroblasts. The same ingredient is used for both the skin booster and the volumizing version — what differs is the formulation, the layer it is placed in, and the technique used to deliver it. A prospective split-face randomized study has evaluated PDLLA for photoaged skin (ClinicalTrials.gov NCT05913102), and a clinical study of the lower eyelid area reported improvement with high patient satisfaction and mostly minor adverse effects (PMC). As with any injectable collagen stimulator, technique and dosing matter — see the downtime section below.
Exosome therapy. Here honesty matters: in the United States, the FDA has not approved any exosome products, and it has issued a public safety notification about unapproved exosome offerings (FDA). In Korea, exosome solutions are widely used as a topical adjunct with procedures such as microneedling RF, not as an injected drug. We think patients deserve to know this context before paying extra for it. It can be a reasonable add-on for post-procedure calming and skin quality, but it should not be sold as a proven standalone treatment.
Orta Clinic publishes event pricing openly on its promotions page. Prices below are as of September 2026 and change from month to month as promotions rotate.
Treatment | Regular price | Event price |
|---|---|---|
Rejuran Healer 2cc | KRW 370,000 | KRW 189,000 |
Rejuran Eye 1cc | KRW 252,000 | KRW 129,000 |
Rejuran HB 1cc | KRW 194,000 | KRW 99,000 |
Painless Rejuran (with lidocaine) 3cc | KRW 703,000 | KRW 359,000 |
Painless Rejuran Eye (with lidocaine) 3cc | KRW 703,000 | KRW 359,000 |
Juvelook Volume 4cc | KRW 880,000 | KRW 449,000 |
Juvelook Skin Booster 2cc | KRW 621,000 | KRW 317,000 |
Juvelook Skin Booster 1cc — first-visit special* | KRW 135,000 | KRW 69,000 |
Juvelook Eye Volume 2cc | KRW 621,000 | KRW 317,000 |
Exosome 5cc | KRW 370,000 | KRW 189,000 |
*The Juvelook Skin Booster 1cc price is a first-visit special. It is available once per patient, on a first visit only, and does not apply to treatments of 2cc or more.
A few practical points for international patients:
All prices are exclusive of VAT. 10% VAT is added separately at payment.
Payment is made after your visit.
Event prices are time-limited and change monthly, so the price on the date you book may differ from the table above.
Rejuran and Juvelook each come in several versions — different formulations, concentrations, and injection areas. Which one suits you, and how many cc you actually need, is not something that can be decided from a price list. An in-person consultation is the only way to get an accurate plan and quote, and the final quote is always confirmed before any treatment begins.
"Can I go sightseeing the day after Juvelook?" Usually yes. Most people have mild redness or small bumps at injection points for one to a few days, which can typically be covered with makeup after 24 hours. Strenuous exercise, saunas, and heavy alcohol are best avoided for a few days.
"Are bumps or nodules after Juvelook a real risk?" Small temporary bumps at injection sites are common and settle as the product integrates. Persistent nodules are uncommon but documented with PDLLA injections, and published case reports describe how they are managed (PMC). This risk is one reason injector experience and conservative dosing matter. Orta Clinic performs all procedures doctor-administered in private treatment rooms, and aftercare instructions are provided in English.
"Is Rejuran okay for sensitive or acne-prone skin?" Often yes — polynucleotide injections are also used to support the skin barrier — but active acne flare-ups or skin infections need to be assessed first. This is decided at consultation, not in advance.
Visitors on a short trip often ask whether Rejuran and exosome therapy can be done on the same day. In many cases yes — for example, a microneedling RF session with topical exosomes plus a skin booster injection can be scheduled in a single visit of roughly 60–90 minutes. Whether a combination is appropriate for your skin, and in which order, is determined by the doctor at consultation. If you have a fixed departure date, mention it when booking so downtime is planned around your schedule.
Location: 6th–7th floor, Nam Seoul Building, Gangnam-daero 447, Seocho-gu, Seoul — near Gangnam Station and Sinnonhyeon Station.
Language: English-language booking and consultation support for international patients.
Hours: Open weekdays and weekends; closed on Wednesdays and major Korean holidays (Lunar New Year, Chuseok).
Booking: Reserve online at ortaclinic.com/en/reservation. Sedation options are available for eligible treatments with advance reservation.
Approach: All procedures are performed by doctors in private single rooms, with consultation focused on accurate information rather than upselling.
Q. Which is better for glass skin — Rejuran or Juvelook? They target different things. Rejuran mainly improves skin quality and hydration; Juvelook stimulates collagen for elasticity and fine wrinkles. Many patients in their late 20s with dull skin start with Rejuran, while Juvelook suits early elasticity loss — but the recommendation is made after examining your skin.
Q. What is the difference between Juvelook and Juvelook Volume? They use the same ingredient but are placed differently. The skin booster version is injected with a needle just beneath the dermis to improve elasticity, fine wrinkles, and skin that has thinned; Juvelook Volume is placed with a cannula, under a nerve block, into an area where volume needs to be restored.
Q. Is exosome therapy worth the extra cost compared to Rejuran? It depends on what you're pairing it with. Exosomes are an adjunct, not a standalone treatment, and they are not FDA-approved in the US. If your budget covers only one thing, an established injectable like Rejuran or Juvelook is usually the more evidence-supported starting point.
Q. How do I pay as a foreign visitor? Payment is made at the clinic after your visit, with 10% VAT added separately. Bring your passport; reservation names should match your passport spelling.
This article is for general information and does not replace a medical consultation. Individual results vary. Sources: Cureus 2025 systematic review, ClinicalTrials.gov NCT05913102, PMC: PDLLA lower eyelid study, PMC: PDLLA nodule management, FDA exosome safety notification.
Dr.